Control | Parkinson disease, total | Parkinson disease, stage | |||
---|---|---|---|---|---|
Early | Moderate | Advanced | |||
n (male/female) | 14 (8/6) | 42 (30/12) | 15 (13/2) | 13 (8/5) | 14 (9/5) |
Age (yr)* | 62.5 ± 6.5 | 64.5 ± 9.2 | 63.8 ± 10.5 | 58.8 ± 6.6 | 70.5 ± 5.9 |
Disease duration (mo) | – | 61.1 ± 64.4 | 10.5 ± 7.2 | 44.8 ± 17.8 | 130.4 ± 56.2 |
MDS-UPDRS* | |||||
Part I | 2.6 ± 2.4 | 8.0 ± 5.3 | 8.1 ± 6.0 | 7.1 ± 4.5 | 8.6 ± 5.7 |
Part II | 0.1 ± 0.4 | 10.1 ± 6.4 | 8.9 ± 5.8 | 8.7 ± 4.0 | 12.7 ± 8.2 |
Part III | 1.1 ± 2.7 | 26.1 ± 12.0 | 20.1 ± 9.9 | 27.1 ± 11.8 | 31.9 ± 12.1 |
Total | 3.8 ± 4.0 | 44.0 ± 18.8 | 37.2 ± 17.7 | 42.9 ± 14.9 | 52.9 ± 21.1 |